How do you improve compliance?

Sheldon Winnick1, David O Lucas, Adam L Hartman

  • 1hywindoc@hotmail.com

Pediatrics
|June 3, 2005
PubMed

Insights

Pediatric medication compliance is crucial for effective treatment and health promotion, yet achieving it presents significant challenges. Improving physician-patient communication and practice settings can enhance adherence in children.

Area of Science:

  • Pediatric Healthcare
  • Patient Adherence Research
  • Health Communication

Background:

  • Medication compliance, or adherence, is vital for pediatric treatment success, disease prevention, and health promotion.
  • Achieving consistent medication adherence in children is frequently challenging, impacting treatment outcomes.
  • Reported pediatric medication compliance rates vary widely, from 11% to 93%, with at least one-third of patients not completing prescribed regimens.

Purpose of the Study:

  • To examine the incidence and barriers associated with pediatric medication compliance.
  • To present general principles for improving medication adherence in pediatric patients.
  • To highlight the importance of physician-patient communication and practice setting characteristics in enhancing compliance.

Main Methods:

  • Review of existing studies and physician accounts on pediatric medication compliance.
  • Analysis of factors influencing adherence, including patient-physician relationship and practice environment.
  • Identification of strategies to improve communication and adherence.

Main Results:

  • Significant difficulties exist in achieving pediatric medication compliance.
  • Poor compliance poses risks including disease progression and complicates care assessment.
  • A strong one-on-one physician-patient relationship is essential for effective communication and improved adherence.

Conclusions:

  • Improving pediatric medication compliance requires a focus on enhancing communication and optimizing practice settings.
  • Strengthening the physician-patient relationship is a key strategy for boosting adherence.
  • Addressing compliance barriers is critical for successful pediatric healthcare and patient well-being.

Related Concept Videos

Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Cyclohexenones via Michael Addition and Aldol Condensation: The Robinson Annulation01:27

Cyclohexenones via Michael Addition and Aldol Condensation: The Robinson Annulation

Robinson annulation is a base-catalyzed reaction for the synthesis of 2-cyclohexenone derivatives from 1,3-dicarbonyl donors (such as cyclic diketones, β-ketoesters, or β-diketones) and α,β-unsaturated carbonyl acceptors. Named after Sir Robert Robinson, who discovered it, this reaction yields a six-membered ring with three new C–C bonds (two σ bonds and one π bond).
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Stability of Substituted Cyclohexanes02:30

Stability of Substituted Cyclohexanes

This lesson discusses the stability of substituted cyclohexanes with a focus on energies of various conformers and the effect of 1,3-diaxial interactions.
The two chair conformations of cyclohexanes undergo rapid interconversion at room temperature. Both forms have identical energies and stabilities, each comprising equal amounts of the equilibrium mixture. Replacing a hydrogen atom with a functional group makes the two conformations energetically non-equivalent.
For example, in...